High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder

Author: Patrick A.   Wee A.   Hedderman A.   Wilson D.   Weiss J.   Govani M.  

Publisher: Springer Publishing Company

ISSN: 0167-594X

Source: Journal of Neuro-Oncology, Vol.103, Iss.3, 2011-07, pp. : 739-743

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content